Categories AlphaGraphs, Health Care

Key highlights from Biogen’s (BIIB) Q1 2022 earnings results

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today.

Total revenue decreased 6% year-over-year to $2.53 billion.

GAAP net income attributable to Biogen Inc. was $304 million, or $2.06 per share, compared to $410 million, or $2.69 per share, last year. Adjusted EPS amounted to $3.62.

For full-year 2022, total revenue is estimated to be $9.7-10 billion while adjusted EPS is expected to be $14.25-16.00.

Prior performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Viewing Highlight